Double Blind, Placebo Controlled Study of Safety and Efficacy of Leronlimab in Patients With "Long" COVID-19

Clinical trial NCT04678830 · COMPLETED

Trial details

NCT number: NCT04678830
Sponsor: CytoDyn, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Coronavirus Disease 2019

Start date: 2021-03-01
Primary completion: 2021-06-05
Enrollment: 56

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.